The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
Kelminski
Ann
A
STAR Trial, Cancer Research Center of Hawaii, USA.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D004608:Eligibility Determination; D005260:Female; D006254:Hawaii / Q000453:epidemiology; D006801:Humans; D010358:Patient Participation; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride